Skip to Content

Dihydrocodeine use while Breastfeeding

Drugs containing Dihydrocodeine: Coldcough Syrup, Trezix, Panlor DC, Panlor, Synalgos-DC, Coldcough PD, Donatuss DC, Panlor SS, Dvorah, DHC Plus, Show all 36 »Zerlor, Centussin DHC, Poly-Tussin DHC, EndaCof-DH, J-Cof DHC, Novahistine DH, DiHydro-PE, Pancof-PD, Despec-PD, Duohist DH, Tusscough DHC, Pancof, Tricof, Hydro-Tussin DHC, Dihydro-CP, Uni-Cof, J-Max DHC, Poly-Tussin EX Syrup, Poly Tussin EX, DiHydro-GP, Uni-Cof Expectorant, Hydro-Tussin EXP, Pancof EXP, Welltuss EXP, Alahist DHC, Poly Hist DHC

Medically reviewed by Drugs.com. Last updated on Jul 21, 2021.

Dihydrocodeine Levels and Effects while Breastfeeding

Summary of Use during Lactation

Maternal use of oral narcotics during breastfeeding can cause infant drowsiness, central nervous system (CNS) depression and even death. Like codeine, pharmacogenetics probably plays a role in the extent of CNS depression. Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. Dihydrocodeine possibly caused severe respiratory depression in one newborn infant whose mother was taking the drug for cough. Once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of hydromorphone to a few days at a low dosage with close infant monitoring. If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately. Because there is little published experience with dihydrocodeine during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Dihydrocodeine is metabolized via CYP2D6 to the active metabolite, dihydromorphine, which has a potency similar to morphine. Other weakly active metabolites include nordihydrocodeine, which is formed via CYP3A4, and dihydrocodeine-6-glucuronide. Both dihydrocodeine and dihydrocodeine-6-glucuronide are excreted renally.[1]

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

A woman began taking dihydrocodeine drops for cough twice daily (5.28 mg) beginning on the first day postpartum. One day later, her breastfed infant was difficult to arouse and was not breastfeeding well. The infant had bradycardia, hypoglycemia, and an oxygen saturation of 85%. After 24 hours in the hospital, all symptoms resolved. The symptoms were possibly caused by dihydrocodeine in milk.[2]

Effects on Lactation and Breastmilk

Narcotics can increase serum prolactin.[3] However, the prolactin level in a mother with established lactation may not affect her ability to breastfeed.

Alternate Drugs to Consider

(Analgesia) Acetaminophen, Butorphanol, Hydromorphone, Ibuprofen, Morphine; (Antitussive) Dextromethorphan

References

1.
Kirkwood LC, Nation RL, Somogyi AA. Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine. Br J Clin Pharmacol. 1997;44:549–55. [PMC free article: PMC2042888] [PubMed: 9431830]
2.
Eleftheriou G, Butera R, Davanzo F, et al. Dihydrocodeine and breast feeding: A case report. Birth Defects Res A Clin Mol Teratol. 2014;100:540. Abstract.
3.
Tolis G, Dent R, Guyda H. Opiates, prolactin, and the dopamine receptor. J Clin Endocrinol Metab. 1978;47:200–3. [PubMed: 263291]

Substance Identification

Substance Name

Dihydrocodeine

CAS Registry Number

125-28-0

Drug Class

Breast Feeding

Lactation

Analgesic, Opioid

Narcotics

Antitussive Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.